More than 5,000 patient-reported outcomes (PRO) surveys have now been collected from 1,700+ patients across 43 centers.
This major achievement highlights our continued dedication to advancing cell therapy and our active effort to improve patient outcomes. These valuable data insights are now available through the CIBMTR Research Database Protocol.
Visit the PRO Protocol webpage for an updated data listing. The data are available by patient demographics and PRO time points.
We invite you to join our collaborative research community by proposing a CIBMTR Working Committee Study.
Your involvement will help advance the PRO protocol’s mission to capture patient-reported symptoms and functioning —driving forward patient-centered research in cell and gene therapy.
If you’d like to learn more about PRO data, or to ensure your patients are included in the PRO Protocol, please reach out to our study team at Surveys@cibmtr.org.